Scientific Papers
Article
News
Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections (LRTI) in children.
Scientific Papers
News
Article
Omicron BA.2 breakthrough infection elicits CD8+ T cell responses recognizing the spike of later Omicron subvariants
Recent studies have suggested that memory T cells play a critical role in protecting individuals immunized with SARS-CoV-2 vaccines against variants
News
Article
Scientific Papers
Real-World Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents
The efficacy of the BNT162b2 vaccine in pediatrics was assessed by randomised trials before the Omicron variant’s emergence.
Scientific Papers
Article
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults
Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality among older adults.
Article
Scientific Papers
Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study
Previous comparative analyses of people admitted to hospital for COVID-19 versus influenza evaluated the risk of death, hospital readmission, and a narrow set of health outcomes up to 6 months following infection.
News
Scientific Papers
Article
Assessing the health burden of vaccine-preventable infections in European adults: challenges and opportunities translated into action
Accurate information on the health burden of vaccine-preventable infections (VPIs) is needed to support evidence-informed vaccine policy recommendations and programmes in Europe.
Article
News
Scientific Papers
The Adult Immunization Board (AIB): A new platform to provide multidisciplinary guidelines for the implementation and optimization of adult immunization in Europe
People can be at risk of getting and spreading serious vaccine-preventable infectious diseases throughout their lives and can therefore benefit from a lifelong approach to vaccination.
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions
Mycoplasma pneumoniae is a common cause of respiratory tract infections with community-acquired pneumonia as the major disease-related burden.
Scientific Papers
News
Article
Effectiveness of community-based oral antiviral treatments against severe COVID-19 outcomes in people 70 years and over in Victoria, Australia, 2022: an observational study
Oral Antiviral (OAV) COVID-19 treatments are widely used, but evidence for their effectiveness against the Omicron variant in higher risk, vaccinated individuals is limited.
Scientific Papers
Article
News
Factors associated with delayed diagnosis of symptomatic adult COVID-19 cases presenting to primary care: a population-wide study during transition from Delta to Omicron BA.1 in Singapore
During pandemics, avoiding time delay in diagnosing infection is crucial.
Risk of Type 1 Diabetes in Children is Not Increased after SARS-CoV-2 Infection: A Nationwide Prospective Study in Denmark
It has been hypothesized that SARS-CoV-2 infection in children can increase risk of developing type 1 diabetes.
Project FluCov: understanding and communicating the impact of COVID-19 on influenza activity
Nivel is researching the impact of COVID-19 on Influenza activity combining data from around the world.